EdgarLookup

KORMAN HARRY

Insider transactions at 1 company

This page shows all SEC Form 4 filings attributed to KORMAN HARRY. Form 4 disclosures are required whenever a corporate insider — director, officer, or 10%+ shareholder — buys, sells, or receives company stock. Each row represents a separate reported transaction. All data is sourced directly from the SEC EDGAR public database.

VTRS
Company Title Type Shares Price Value Date
VTRS Option Exercise 18,204 — — Mar 4, 2025
VTRS Option Exercise 885 — — Mar 3, 2024
VTRS Option Exercise 705 — — Mar 4, 2023
VTRS Option Exercise 166 — — Mar 21, 2022
VTRS Purchase 349 $13.94 $4,865 Mar 4, 2022
VTRS Option Exercise 335 — — Mar 2, 2022
VTRS Option Exercise 9,440 — — Mar 2, 2021
VTRS Award / Grant 26,515 — — Nov 16, 2020
0001623613 Disposition 26,515 — — Nov 16, 2020
0001623613 Tax Withholding 2,430 $17.48 $42,476 Mar 2, 2020
0001623613 Tax Withholding 1,882 $27.45 $51,661 Mar 2, 2019
0000069499 Chief Operating Officer Sale 31,970 $54.54 $1,743,644 Mar 6, 2014
0000069499 Chief Operating Officer Tax Withholding 5,613 $55.57 $311,914 Mar 2, 2014
0000069499 Chief Operating Officer Tax Withholding 1,937 $51.92 $100,569 Feb 22, 2014
0000069499 Chief Operating Officer Sale 9,814 $41.94 $411,599 Dec 11, 2013
0000069499 Chief Operating Officer Option Exercise 8,230 $12.15 $99,995 Mar 18, 2013
0000069499 Chief Operating Officer Tax Withholding 3,618 $30.10 $108,902 Mar 2, 2013
0000069499 Chief Operating Officer Tax Withholding 1,867 $28.98 $54,106 Feb 22, 2013
0000069499 Chief Operating Officer Option Exercise 28,188 $12.15 $342,484 Nov 6, 2012
0000069499 Chief Operating Officer Tax Withholding 584 $23.16 $13,525 Mar 2, 2012
0000069499 President, North America Option Exercise 5,300 $7.89 $41,817 Jan 22, 2008
0000069499 President, North America Option Exercise 6,000 $7.89 $47,340 Nov 13, 2007
0000069499 Pres., Mylan Pharmaceuticals Option Exercise 10,000 $7.89 $78,900 Jul 26, 2007
0000069499 Pres., Mylan Pharmaceuticals Tax Withholding 1,476 $21.91 $32,339 Feb 14, 2007
0000069499 Pres., Mylan Pharmaceuticals Option Exercise 120,000 $10.97 $1,316,400 Dec 14, 2006
0000069499 Pres., Mylan Pharmaceuticals Award / Grant 13,298 — — Feb 15, 2006